Introduction: Robotic prostatectomy is considered by many urologists as the new standard of care.
INTRODUCTION
It is very common for a patient with a patent foramen ovale (PFO) to be scheduled for a surgical procedure with risk of gas embolism. A singular feature is the case of a patient who had suffered from a previous complication related to the PFO such as a cerebral stroke. We encountered 2 such cases and decided to perform a preventive closure of the PFO.
CASE 1 DESCRIPTION
The first patient was a 50-year-old man scheduled for robotic prostatectomy. He had suffered from a left ischemic rolandic cerebral palsy 6 months previously with no significant sequelae. At that time, transesophageal echocardiography (TEE) had revealed a PFO. As all other investigations were negative, it was considered highly probable that the stroke was due to a paradoxical embolism. Cardiologists had recommended aspirin, but they had decided that closure was not necessary. The question of the relevance of foramen ovale closure was raised again during the anesthetic consultation due to the risk of paradoxical gas embolism. The surgical team considered that it would be a loss of chance to perform a radical prostatectomy via laparotomy. The patient consulted a cardiologist, who specialized in PFO closure, and accepted this procedure after receiving benefit and risk information. Percutaneous closure (Amplatzer device; St. Jude Medical, Plymouth, Minnesota) performed under local anesthesia was uneventful, followed by a 3-month treatment with clopidogrel and aspirin. Robotic prostatectomy was then performed without any adverse effects; notably, there was no sign of gas embolism. Postoperative course was uneventful and the patient was well 6 months after surgery.
CASE 2 DESCRIPTION
The second patient was a 68-year-old man scheduled also for robotic prostatectomy. He had suffered 6 years earlier from a motor deficit of the right arm with no significant sequelae. At that time, transthoracic echocardiography had revealed a PFO with an atrial septal aneurysm. Cardiologists had recommended aspirin and decided that closure was not necessary. As in the previous case, the question of the relevance of closure was raised during the anesthetic consultation, and it was decided to adopt the same strategy. In this case, the delay between the percutaneous PFO closure and the robotic prostatectomy was only 1 month. These procedures were performed without any adverse effect. Postoperative course was uneventful, and the patient was well 6 months after surgery.
DISCUSSION
Abnormalities in the atrial septum range in severity from PFO to atrial septal defects.
The normal atrial septum consists of 2 layers-the septum primum and the septum secundum. The septum primum forms first, but leaves a window, the ostium secundum. The septum secundum forms later and usually covers the ostium secundum. An atrial septal defect appears if the septum secundum fails to cover the ostium secundum and results in a left-to-right shunt, which causes a volume overload of both the right atrium and the right ventricle. With time, this condition can result in pulmonary hypertension, and reversal of the pressure gradient across the atrial septal defect causes the shunt to reverse as a rightto-left shunt (ie, Eisenmenger syndrome) with cyanosis.
An atrial septal defect is present in 0.70 of 1000 persons while the prevalence of a PFO, evaluated by Hagen et al 1 from autopsy specimens of human hearts, is 27.3% with a progressive decline with increasing age from 34.3% during the first 3 decades of age to 25.4% during the 4th through 8th decades and 20.2% during the 9th and 10th decades. The origin of a PFO is completely different from that of an atrial septal defect. A portion of the blood from the inferior vena cava passes from the right to the left atrium through the PFO during fetal life, bypassing the lungs. Pulmonary blood flow increases greatly during neonatal circulatory transition, causing increased left atrial pressure. The resulting atrial pressure differences compress the septum primum against the septum secundum, functionally closing the PFO, but this anatomic closure is incomplete in approximately 1 of every 4 adults. Therefore, PFO should be considered a normal anatomic variant and not a pathological finding in the absence of possible paradoxical embolism or other specific clinical conditions. 2 The physiological implications of a PFO vary depending on interatrial pressure gradient and streaming. Of prime importance is any situation during which right atrial pressure becomes greater than left atrial pressure: pulmonary embolism of any mechanism, Valsalva maneuver, mechanical ventilation with a positive end-expiratory pressure, etc.
To our knowledge, there are only 2 published cases of a closure of a PFO before a scheduled surgical procedure. The first was a young patient who had a post-traumatic fat embolism syndrome. PFO closure was performed before the surgical repair of a femoral fracture. 3 The second was a 74-year-old woman scheduled for a total hip replacement; she had suffered 2 consecutive cerebellar ischemic strokes that were considered to be paradoxical embolisms. Indeed, TEE revealed an interatrial septum aneurysm with a PFO. 4 On the other hand, Thoma et al 5 described the case of a patient having a large PFO without any related sign scheduled for a cholecystectomy; finally they retained a laparoscopic approach.
Laparoscopic procedures expose a high risk of carbon dioxide embolism. Hong et al 6 reported a 17.1% (95% confidence interval of 0.138%-0.204%) occurrence of carbon dioxide embolism using TEE during laparoscopic radical prostatectomy. Their report confirms this wellknown potential complication of all surgical procedures using carbon dioxide insufflation, with some carrying up to a 100% risk such as total laparoscopic hysterectomy. 7 Robotic prostatectomy carries probably the same risk of gas embolism as laparoscopic radical prostatectomy as both procedures use carbon dioxide insufflation.
Massive intravascular irruption of carbon dioxide can cause an acute increase of right ventricular afterload that could lead to low cardiac output or even to death, as in a recently published case. 8 On the opposite, intravascular bubbles of carbon dioxide are generally considered safe, because of the high solubility of carbon dioxide in the blood (Ostwald solubility coefficient 0.49), which is 20 times greater than that of oxygen and it is regularly reported that carbon dioxide bubbles disappear within 20 to 30 seconds. However, this image of short-lived bubbles is incorrect because carbon dioxide is used as an intravascular contrast agent, particularly for patients with renal insufficiency or with high risk of allergic reaction to standard contrast media that require vascular imaging. 9 Thus, in an extensive review on carbon dioxide angiography, Cho and Hawkins 10 reported that carbon dioxide bubbles completely dissolve within 2 to 3 minutes when injected into a vessel. These investigators recommend that 3 minutes should elapse between injections of carbon dioxide to prevent the localized accumulation of gas bubbles. This time is obviously longer than the circulation time; there- fore, carbon dioxide bubbles injected intravenously can reach the right atrium and the aorta, especially when the right to left heart interval time is reduced by a PFO. This explains why a patient can suffer from pulmonary artery hypertension with transient symptomatic hypotension after a carbon dioxide injection. 11 Accordingly, Cho and Hawkins 10 stated that carbon dioxide should be used with caution in patients with pulmonary insufficiency or pulmonary hypertension because of the risk of pulmonary arterial pressure and should not be used in patients with an intracardiac septal defect or a pulmonary arteriovenous malformation because of the possibility of paradoxical gas embolism.
Carbon dioxide bubbles that have reached the right heart have several possible issues. They can be filtered by the lungs, 12 but this filter is limited in case of a large volume of gas. They can create an acute right ventricular outflow obstruction as in the well-described case of a patient who suffered from carbon dioxide embolism during minimally invasive saphenous vein harvesting. 13 Finally, carbon dioxide bubbles can reach the left heart through a PFO or less frequently through an arteriovenous malformation resulting in intrapulmonary shunting. The complications that follow, particularly cerebral complications, are due to the arteriolar obstruction. Obstruction is mainly due to the transformation of gas bubbles to "solid" bubbles because of platelet adhesion. 14 Such solid bubbles act like foreign bodies causing ischemia and local inflammatory cascade with a prothrombotic effect. 15 Otherwise, carbon dioxide induces local toxicity with major local acidosis induced by the gas diffusion, and finally a general inflammatory reaction due to liberation of cytokines from the injured arterial endothelium. 16 Despite these well-known complications reported in multiple clinical cases, Thoma et al 5 chose not to close the PFO of a patient scheduled for a laparoscopic cholecystectomy and known to have this defect. Their principal points were the safety of small intravascular quantities of carbon dioxide because of the high solubility of carbon dioxide with rapid absorption of bubbles 17 and the reversal of clinical signs of carbon dioxide embolism. Thoma et al 5 cited the use of carbon dioxide for angiography to reinforce the low risk of their intravascular injection, but they also wrote that cerebral angiography with carbon dioxide contrast is considered unsafe, with bubble-related vaso-occlusion. 18 Finally, Thoma et al 5 concluded that the benefits of laparoscopic surgery, with better postoperative course after laparoscopic procedures compared with open surgery, greatly exceed the immeasurably small risk of paradoxical emboli. Their consensus plan was to perform the laparoscopic cholecystectomy during general anesthesia using intraoperative TEE monitoring in addition to standard anesthesia monitoring. This plan was explained to the patient, who wanted more time to reflect on the risks, went back home, and had no surgery.
We followed the same steps as Thoma et al 5 : analysis of the literature and discussion with the surgical team and a specialized cardiologist. We came to a completely different conclusion: preoperative prophylactic closure of the PFO and a subsequent laparoscopic procedure. Both procedures were uneventful. Findings of a recent study, 19 showing that patients with permanent right-to-left shunt have potentially a higher risk of paradoxical embolism compared with those with Valsalva manoeuver-induced right-to-left shunt could perhaps help in such cases.
A problematic issue for anesthesiologists is neurosurgical procedures performed in the sitting position that carry a high risk of air embolism, around one-third of the cases. A Swiss team proposes a systematic preoperative screening for PFO and its closure when the sitting position is the preferred neurosurgical approach. 20 Among the numerous studies on the technical aspect of the percutaneous PFO closure, one of the most recently reported is the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke or TIA due to the Possible Passage of a Clot of Unknown Origin Through a Patent Foramen Ovale [PFO]) study, which evaluated the STARFlex septal closure system (NMT Medical, Inc, W. L. Gore & Associates, Inc, Flagstaff, Arizona). The rate of effective PFO closure was 86%, and the occurrence of major vascular procedural complications was 3.2%. 21 Finally, even if the collateral benefit of PFO closure in general is out of our scope, it must be known that percutaneous PFO closure is more effective than medical treatment for the secondary prevention of recurrent cerebrovascular events among patients with PFO-related transient ischemic attack or stroke. 22 
CONCLUSIONS
Prophylactic closure of a PFO before a procedure at risk of gas embolism is unusual. Some facts are well established: the occurrence of gas embolism is high during laparoscopic procedures; percutaneous closure is a highly successful and very low risk procedure. But the clinical decision in patients with known PFO, a fortiori when they have suffered from a previous paradoxical embolism, is difficult and must involve a fully informed patient. Our cases were patients submitted to robotic radical prostatectomy but similar cases are encountered in patients requiring much more frequent proce-dures such as laparoscopic cholecystectomy. The question of medical attitude is even more difficult in these cases. Derouin et al 23 have demonstrated using TEE that gas embolism occurs commonly during this procedure. A few major complications, including deaths, have been reported to be the consequence of carbon dioxide embolism. Case reports have a low level of evidence, but their interest is to show that the problem exists.
